Questcor Pharmaceuticals, Inc. (QCOR): Here’s What Mr. Market Thinks
Many believed that Q1 earnings would be the start of a larger trend higher that reversed the losses seen in shares of Questcor Pharmaceuticals, Inc.
Posts Tagged ‘Questcor Pharmaceuticals Inc. (QCOR)’
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Herbalife Ltd. (HLF), Gold Fields Limited (ADR) (GFI): One Investor’s Trash is Another Investor’s Treasure
Have you ever been dumpster diving? I have--it is a great past time. One thing I've learned is that you never know what some people will throw away.
Sarepta Therapeutics Inc (SRPT) Is A Gamble Worth Taking
There is always something interesting happening in the Bio-Pharma sector due to a number of firms working on several new drugs.
Theravance Inc (THRX): Here’s One Thing To Know About The Stock Today
Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world's most elite money managers of late, but insiders on the whole appear bullish.
Coinstar, Inc. (CSTR), SodaStream International Ltd (SODA) Among The NASDAQ’s Five Most Hated Stocks
Although the Nasdaq Composite is the only major U.S. index that's nowhere near its all-time high, it still turned in an impressive gain of 8.2% for the quarter.
Does Questcor Pharmaceuticals Inc (QCOR)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
2 Fallen Growth Stocks: 1 to Buy & 1 to Sell! – Mellanox Technologies, Ltd. (MLNX), Questcor Pharmaceuticals Inc (QCOR)
A large downtrend is often a normal part of any stock’s life cycle.
Spectrum Pharmaceuticals, Inc. (SPPI): When Being “Long” Backfires!
Yesterday, I published an article titled, “When Being Short Backfires!” So it's only appropriate to look at the other side of the trade.
Expand Your Investing Horizons With These Three Options Strategies: Zagg Inc. (ZAGG), Questcor Pharmaceuticals Inc (QCOR)
Stock options can induce fear in even the savviest of investors.
Questcor Pharmaceuticals Inc (QCOR) Will Carry On its Rise: VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
Some companies were happy to see the end of 2012. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) was one of them.
Dollar Tree, Inc. (DLTR), Questcor Pharmaceuticals, Inc. (QCOR): Three Stocks to Buy After Earnings
Earnings can dictate the direction of a stock for the following three months.
5 Reasons Not to Worry This Week: Groupon Inc (GRPN), MAKO Surgical Corp. (MAKO)
Let's start at the top with Questcor. The drugmaker's multifaceted Acthar gel isn't cheap at $23,000 per vial, and its marketing practices are being probed by the U.S.
5 Can’t-Miss Health-Care Events This Week: Zogenix, Inc. (ZGNX), Ariad Pharmaceuticals, Inc. (ARIA)
Normally we have a nice blend of health-care events to take notice of each week.
3 Humongous Health-Care Stocks This Week: Infinity Pharmaceuticals Inc. (INFI)
There's power in positive thinking. The late author Norman Vincent Peale made plenty of money off that philosophy.
This News Should Get Your Blood Pumping: ABIOMED, Inc. (ABMD), Amgen, Inc. (AMGN)
Following the close of the bell yesterday, ABIOMED released a statement announcing that U.S.
Dow Jones Industrial Average (.DJI)’s Bumpy Ride Keeps It in Positive Territory
The Dow Jones Industrial Average (INDEX:.DJI) has had a wild ride this morning, but stayed up nevertheless.
7 Biotech Stocks Trading At Steep Discount To Target Price
Last year we screened US-traded biotech stocks for those trading at the steepest discount to the most pessimistic analyst target prices.
Hedge Fund News: Marc Faber, Carl Icahn, BlackRock
America’s central bank, the Federal Reserve, will eventually destroy the world economy, says respected Swiss investor Marc Faber.
3 Cheap Potential Rebound Stocks from Q3’s Biggest Losers
Did you have the misfortune of owning for-profit education stocks in the third quarter? Then you're likely licking your wounds right now, and presumably, cutting your losses.
